FTRE Fortrea Holdings Inc Total Asset Value of Company

FTRE (Fortrea Corp) - company brandmark

This daily price chart for Fortrea Holdings Inc. (FTRE) reflects total assets, which currently stand at 2737.05. Fortrea Holdings Inc. (FTRE) generates revenue through long-term medical test support, where strict regulations ensure a steady income stream. The business is currently fighting for influence within the sector by optimizing internal operational cycles without reducing prices. Process stability is maintained through the professional transportation of biological materials under strict temperature control.

FTRE (Fortrea Holdings Inc.) Company Total Assets history from 02/21/2024 to 11/01/2026

Analytical breakdowns and data insights for company Fortrea Corp (FTRE)

- stock value and consensus price forecast:
Market Price fortrea.com|FTRE - Price Target Chart
- market capitalization data:
Market Valuation Fortrea Clinical|FTRE - Enterprise Value
- issuer book value statistics:
Accounting Value of a Share Fortrea|FTRE - Book Capitalization|Market Capitalization to Book Value Ratio fortrea.com|FTRE - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Fortrea Holdings Inc.|FTRE - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Fortrea Clinical|FTRE - Company Aggregate Debts|Debts to Book Capitalization Fortrea Clinical|FTRE - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Fortrea|Intermediate Liquidity Ratio fortrea.com
- net income and valuation multiples indicators:
FTRE - Net Profit
Fundamental valuation:Fortrea Holdings Inc.
Manufactured products of Fortrea Holdings Inc.

Total assets represent the aggregate volume of the company's resources and property, calculated inversely via ROA to monitor capital dynamics between reporting periods. An analysis of consolidated asset levels allows for an assessment of the resource base of Fortrea Holdings Inc., where effective management of global biosample logistics infrastructure ensures high margins and operational business resilience.

Key competitors

Company Assets iqvia.com (IQV)|Aggregate Company Assets Labcorp|Medpace Holdings - Total Asset Value of Company|Company Total Assets ICLR|CRL (Charles River Corp) - Aggregate Asset Value|Company Total Assets EVO (Evotec SE)|Company Total Assets Lifecore Biomedical Inc. LFCR|OABI - Aggregate Company Assets|Aggregate Asset Value NOTV (Inotiv Inc)|Avid Bioservices, Inc (CDMO) - Aggregate Company Assets|Cumulative Company Assets Catalent, Inc|SCPX (Scorpius Holdings, Inc.) - Company Total Assets